Saturday, August 30, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Public Companies : Healthcare/BioTech


Smith & Nephew PLC - Transaction in Own Shares

Jun 26, 2008 - 12:36:02 PM

News Source MARKET WIRE

Email this article
 Printer friendly page
London, UK -- (MARKET WIRE) -- 06/26/08 --

Transaction in own shares.Smith & Nephew plc announces that on 26 June 2008 it purchased 175,000ordinary shares of USUSD0.20 each at a price of 557.2936 pence per share.The purchased shares will be held as treasury shares.Following the above purchase, Smith & Nephew plcholds 63,299,483 ordinary shares in treasury, andhas 885,605,797 ordinary shares in issue (excluding treasury shares).Paul ChambersCompany Secretary                    This information is provided by RNS          The company news service from the London Stock ExchangeEND

Contacts:
RNS
Customer
Services
0044-207797-4400
Email Contact
http://www.rns.com



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
CLX Medical, Inc. Issues August 2008 Newsletter Highlighting Planned Acquisition of the ThyroTest(R) Rapid Screening Device
New Director of Operations Announced at MIHS
SinoFresh(R) Nasal Spray Kills MRSA "Super-Bug" in Live Noses
Smith & Nephew Plc - Transaction in Own Shares
Oncologix Announces Signing of Asset Purchase Agreement Pertaining to Selling Its Oncosphere Assets
Clinical Studies Completed for HeartVue's 6S Heart Screening System
Trimedyne Enters Into Letter of Intent With FemSuite, LLC
Forbes Medi-Tech Announces Sale of Pharmaceutical Assets
Stellar Pharmaceuticals Inc. Announces Successful Completion of Watson's Pilot Clinical Study
MethylGene Provides Update on Suspension of New Enrollment in MGCD0103 Clinical Trials